INT197096

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.04
First Reported 2006
Last Reported 2006
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.43
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (VEGFA, FLT4) cytoplasm (VEGFA, FLT4) extracellular space (VEGFA)
growth (VEGFA) proteinaceous extracellular matrix (VEGFA) plasma membrane (FLT4)
Anatomy Link Frequency
endothelium 2
VEGFA (Homo sapiens)
FLT4 (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 26 15.36 Low Low
Paracetamol 4 5.00 Very Low Very Low Very Low
Pain 4 5.00 Very Low Very Low Very Low
headache 4 5.00 Very Low Very Low Very Low
drug abuse 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Lymphedema 154 94.32 High High
Targeted Disruption 8 88.08 High High
Disease 36 81.60 Quite High
Lymphatic Filariasis 46 74.24 Quite High
Helminth Infection 120 68.32 Quite High
Keratitis 2 64.92 Quite High
Filariasis 12 33.64 Quite Low
Hydrocele 24 16.92 Low Low
Cancer 14 12.24 Low Low
Necrosis 2 11.76 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Recent studies on the molecular mechanisms controlling the lymphatic vessels have shown that vascular endothelial growth factors C (VEGF-C) and VEGF-D specifically control lymphangiogenesis in humans [27,28] by activating the VEGF receptor-3 (VEGFR-3) [29–32], which is principally restricted to the lymphatic endothelium in adults [33,34].
VEGF Positive_regulation (activating) of VEGFR-3 in endothelium
1) Confidence 0.04 Published 2006 Journal PLoS Pathogens Section Body Doc Link PMC1564427 Disease Relevance 0.71 Pain Relevance 0
Recent studies on the molecular mechanisms controlling the lymphatic vessels have shown that vascular endothelial growth factors C (VEGF-C) and VEGF-D specifically control lymphangiogenesis in humans [27,28] by activating the VEGF receptor-3 (VEGFR-3) [29–32], which is principally restricted to the lymphatic endothelium in adults [33,34].
VEGF Positive_regulation (activating) of VEGFR-3 in endothelium
2) Confidence 0.04 Published 2006 Journal PLoS Pathogens Section Body Doc Link PMC1564427 Disease Relevance 0.72 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox